• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓样及淋巴细胞为主型三阴性乳腺癌中浸润淋巴细胞的特征及空间分布

Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers.

作者信息

Alfaro A, Catelain C, El-Masri H, Rameau P, Lacroix-Triki M, Scoazec J Y, Marty V, Mosele F, Pistilli B

机构信息

Gustave Roussy, UMS AMMICa, CNRS UAR 3655, INSERM US23, 114 rue Edouard Vaillant, Villejuif, F-94805, France.

Gustave Roussy, Department of Medical Oncology- Breast Cancer Unit U981, 114 rue Edouard Vaillant, Villejuif, F-94805, France.

出版信息

NPJ Breast Cancer. 2024 Sep 14;10(1):81. doi: 10.1038/s41523-024-00691-x.

DOI:10.1038/s41523-024-00691-x
PMID:39277640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11401883/
Abstract

Medullary carcinoma of the breast (MedBC) is a rare histological type that accounts for less than 5% of all invasive breast cancers. Here, we performed an exploratory study aimed to determine whether imaging mass cytometry (IMC) can be used to characterize the immune infiltration and the spatial distribution heterogeneity in the rare subtype of MedBC compared to atypical MedBC and TNBC-TILS tumors. In both MedBC and TNBC-TILs, there was a notable enrichment of immune cells in the peripheral regions of the tumors, whereas in atypical MedBC, the immune cells exhibited a central enrichment pattern. This distribution of infiltrated cells reflects an active immune recruitment correlated to more favorable prognosis. In MedBC, spatial analysis shows that immune cells are localized at a greater distance from the tumor cells. IMC highlights the heterogeneity of immune microenvironment across three main subtypes of breast tumors and could help to define distinct immune patterns.

摘要

乳腺髓样癌(MedBC)是一种罕见的组织学类型,占所有浸润性乳腺癌的比例不到5%。在此,我们进行了一项探索性研究,旨在确定与非典型MedBC和三阴性乳腺癌肿瘤浸润淋巴细胞(TNBC-TILS)肿瘤相比,成像质谱流式细胞术(IMC)是否可用于表征这种罕见的MedBC亚型中的免疫浸润和空间分布异质性。在MedBC和TNBC-TILs中,肿瘤周边区域的免疫细胞均显著富集,而在非典型MedBC中,免疫细胞呈现中央富集模式。浸润细胞的这种分布反映了与更有利预后相关的活跃免疫募集。在MedBC中,空间分析表明免疫细胞定位在距肿瘤细胞更远的位置。IMC突出了乳腺肿瘤三种主要亚型中免疫微环境的异质性,并有助于定义不同的免疫模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/866228a36ef1/41523_2024_691_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/5ca13c663d8b/41523_2024_691_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/92b8a24a3584/41523_2024_691_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/acab68f2472b/41523_2024_691_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/866228a36ef1/41523_2024_691_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/5ca13c663d8b/41523_2024_691_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/92b8a24a3584/41523_2024_691_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/acab68f2472b/41523_2024_691_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6355/11401883/866228a36ef1/41523_2024_691_Fig4_HTML.jpg

相似文献

1
Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers.髓样及淋巴细胞为主型三阴性乳腺癌中浸润淋巴细胞的特征及空间分布
NPJ Breast Cancer. 2024 Sep 14;10(1):81. doi: 10.1038/s41523-024-00691-x.
2
Prognosis and effectiveness of chemotherapy for medullary breast carcinoma.髓样乳腺癌化疗的预后和效果。
Breast Cancer Res Treat. 2022 Dec;196(3):635-645. doi: 10.1007/s10549-022-06749-3. Epub 2022 Oct 23.
3
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type.富含肿瘤浸润淋巴细胞的非特殊型浸润性乳腺癌的临床病理特征和免疫细胞亚型分析。
Appl Immunohistochem Mol Morphol. 2023 Jul 1;31(6):354-362. doi: 10.1097/PAI.0000000000001125. Epub 2023 Jun 5.
4
Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis.三阴性乳腺癌的组织学异质性:国家癌症中心数据库分析。
Eur J Cancer. 2018 Jul;98:48-58. doi: 10.1016/j.ejca.2018.04.011. Epub 2018 Jun 2.
5
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.肿瘤内 CD8+ 肿瘤浸润淋巴细胞对髓样癌的诊断意义。
Hum Pathol. 2017 Dec;70:129-138. doi: 10.1016/j.humpath.2017.10.020. Epub 2017 Nov 6.
6
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.MxA表达与肿瘤浸润淋巴细胞相关,是三阴性乳腺癌的一个预后因素。
Breast Cancer Res Treat. 2016 Apr;156(3):597-606. doi: 10.1007/s10549-016-3786-z. Epub 2016 Apr 13.
7
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.一种免疫分层揭示了PD-1/LAG-3双阳性三阴性乳腺癌的一个亚群。
Breast Cancer Res. 2016 Dec 3;18(1):121. doi: 10.1186/s13058-016-0783-4.
8
Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast.肿瘤浸润 B 细胞和 T 细胞与三阴性乳腺癌的术后预后相关。
BMC Cancer. 2021 Mar 16;21(1):286. doi: 10.1186/s12885-021-08009-x.
9
Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.乳腺癌肿瘤浸润淋巴细胞的异质性及其预后意义。
Histopathology. 2018 Dec;73(6):887-896. doi: 10.1111/his.13695. Epub 2018 Oct 9.
10
Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.淋巴细胞为主型乳腺癌中的微卫星不稳定性和错配修复蛋白表达。
Cancer Sci. 2020 Jul;111(7):2647-2654. doi: 10.1111/cas.14500. Epub 2020 Jun 13.

本文引用的文献

1
Spatial predictors of immunotherapy response in triple-negative breast cancer.三阴性乳腺癌免疫治疗反应的空间预测因子。
Nature. 2023 Sep;621(7980):868-876. doi: 10.1038/s41586-023-06498-3. Epub 2023 Sep 6.
2
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type.富含肿瘤浸润淋巴细胞的非特殊型浸润性乳腺癌的临床病理特征和免疫细胞亚型分析。
Appl Immunohistochem Mol Morphol. 2023 Jul 1;31(6):354-362. doi: 10.1097/PAI.0000000000001125. Epub 2023 Jun 5.
3
Protein Profiling of Breast Cancer for Treatment Decision-Making.
乳腺癌治疗决策的蛋白质组学分析。
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-9. doi: 10.1200/EDBK_351207.
4
Medullary breast cancer is a predominantly triple-negative breast cancer - histopathological analysis and comparison with invasive ductal breast cancer.髓样乳腺癌主要是三阴性乳腺癌——组织病理学分析及与浸润性导管癌的比较。
Arch Med Sci. 2019 Jul 17;18(2):432-439. doi: 10.5114/aoms.2019.86763. eCollection 2022.
5
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer.成像质谱流式细胞术和多平台基因组学描绘了乳腺癌的表型基因组图谱。
Nat Cancer. 2020 Feb;1(2):163-175. doi: 10.1038/s43018-020-0026-6. Epub 2020 Feb 17.
6
Invasive Breast Carcinoma of No Special Type with Medullary Pattern: Morphological and Immunohistochemical Features.非特殊型浸润性乳腺癌伴髓样模式:形态学和免疫组织化学特征。
Turk Patoloji Derg. 2022;38(3):205-212. doi: 10.5146/tjpath.2021.01559.
7
The 2019 World Health Organization classification of tumours of the breast.《2019年世界卫生组织乳腺肿瘤分类》
Histopathology. 2020 Aug;77(2):181-185. doi: 10.1111/his.14091. Epub 2020 Jul 29.
8
The single-cell pathology landscape of breast cancer.乳腺癌的单细胞病理学图谱。
Nature. 2020 Feb;578(7796):615-620. doi: 10.1038/s41586-019-1876-x. Epub 2020 Jan 20.
9
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学院临床实践指南的重点更新。
J Clin Oncol. 2018 Jul 10;36(20):2105-2122. doi: 10.1200/JCO.2018.77.8738. Epub 2018 May 30.
10
Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.《美国癌症联合委员会(AJCC)癌症分期手册》第八版:乳腺癌
Ann Surg Oncol. 2018 Jul;25(7):1783-1785. doi: 10.1245/s10434-018-6486-6. Epub 2018 Apr 18.